cancers / tumor / gastric cancer / Uterine Cancer / pathways cancer / breast cancers / Uterine Serous Carcinoma / Cancer / tumors / disease / gynecological cancer / endometrial tumors / USC tumor / Endometrial cancer / II endometrial cancer / able disease / relatively rare tumor / /
MedicalTreatment
chemotherapy / /
Organization
Yale School / Yale / National Academy / Smilow Cancer Hospital / Biology Institute / /
Person
Richard Lifton / Joseph Schlessinger / Alessandro Santin / PETER BAKER / /
Position
Director of the Cancer way / Professor of Obstetrics / Gynecology & Reproductive Sciences / Clinical Research Program Leader / Professor of Genetics and Professor / Professor of amplification of this gene / /
PETER BAKER forefront “It’s a unique opportunity for our USC patients because we will soon be able to translate our discoveries into novel therapeutics that will improve patient outcomes.”